• Aucun résultat trouvé

What made Timor-Leste successful in eliminating measles and controlling rubella?

N/A
N/A
Protected

Academic year: 2022

Partager "What made Timor-Leste successful in eliminating measles and controlling rubella?"

Copied!
3
0
0

Texte intégral

(1)

Timor-Leste has met the criteria for measles elimination and control of rubella and congenital rubella syndrome. To sustain these achievements,

it is important to implement the post-elimination sustainability plan, including the outbreak preparedness and response plan; enhance capacity to strengthen outbreak investigation and response; further strengthen routine immunization for MCV1 and MCV2; enhance local

capacity to strengthen VPD surveillance with focus on measles and rubella; strengthen cross-border initiatives; strengthen and ensure

functioning of surveillance and laboratory system.

What made Timor-Leste successful in eliminating measles and controlling rubella?

 Strong politi cal commitment

 Functi oning health system

 Strengthened routi ne immunizati on coverage

 Enhanced surveillance

 Regular review of programme implementati on at nati onal and subnati onal levels

 Intersectoral collaborati on

 Moti vated workforce

 Community parti cipati on

 Strengthened laboratory networks

 Strong technical assistance

 Coordinated partner support

Measles

and Rubella at a Glance

Timor-Leste, 2018

Flow chart of immunization service delivery system

Mother and Child Health Department

Community Health Service

Health Posts Private Clinic

Na onal Director for Public Health Director General for Service Delivery

Partners HMIS

Partners District Health Service Hospital

Laboratory

Community Outreach

Services

Na onal EPI Program

Immunization coverage at subnational level, 2017

Aileu Ainaro Bobonaro Baucau

Dili Covalima

Ermera Lautem Liquisa Manatuto Manufahi Oecusse Viqueque

0 30 60 90 120 150

Coverage of 1st dose (%) Coverage of 2nd dose (%)

Servisu Integrado Saude Communitario (Integrated Community Health Services)

Programa Nasional Saudena Familia (The Na onal Program of Health in the

Family – Domiciliary Visits)

All images © Shobhan Singh - Communica on O cer/WHO Country O ce for Timor-Leste

(2)

Immunization coverage and no. of measles cases (2002-2016)

Map of risk assessment for measles and rubella transmission

Immunization coverage and no. of rubella cases (2002-2018)

Significant events 2018

Verifi cati on that Timor-Leste has met both goals:

endemic measles eliminated and rubella controlled

2011

Nati onwide measles SIA conducted to provide measles vaccine, Vitamin A and de-

worming tablets

2014

Mandatory reporti ng of measles and rubella cases begun

2006

SIA

conducted for children aged 6 months to 15 years

2003

Supplementary immunizati on acti viti es (SIAs) conducted for children aged 9 months to 5 years

2000

Limited immunizati on services re-established following disrupti on surrounding the struggle for restorati on of

independence

1989

MCV1 introduced

2009

SIA conducted for children aged 9 months to 5 years; measles and rubella case surveillance started

2015

Nati onal Measles Eliminati on Verifi cati on Committ ee formed;

rubella vaccine introduced; MR/OPV catch-up immunizati on campaign conducted

2016

MCV2 introduced;

CRS surveillance started;

2 imported cases of measles reported

Legend says that Timor-Leste was formed out of a crocodile who remembered the kindness of a boy when he saved its life. As a token of grati tude, it fulfi lled the boy’s wish of exploring the world as it carried him on its back, and they travelled the oceans and followed the sun for years. Aft er the crocodile’s death, its rigid back grew to form the mountains and its scales the hills of Timor, becoming the home of the kind boy and his children – the people of Timor-Leste.

In August 2018, Timor-Leste was verifi ed by the Regional Verifi cati on Commission, an independen

t body of experts, for eliminati ng measles and certi fi ed for control of rubella and congenital rubella syndrome, two years ahead of the target

year 2020. No cases of indigenous virus were reported for more than three years. This has been

possible due to self-fi nancing of immunizati on programme, supplementary immunizati on acti viti es, improved routi ne immunizati on coverage,

enhanced surveillance and strengthened laboratory networks.

1 261 405

Total populati on

13

Municipaliti es

65

Sub-districts

442

villages (suco)

1

Nati onal Referral Hospital

5

Regional referral hospitals

68

Community health centres at the sub-district level

Timor-Leste: An overview

Measles-SIA 6 months to 14 years (40%)

Measles-SIA 9-59 months

(76%)

Measles-SIA 6 months to 14 years (92%)

Measles-rubella- SIA 9 months to 14 years (96%)

Measles-rubella-SIA 9 months to <5 years

(99.5%) Measles-SIA

9-59 months (99%)

900 800 700 600 500 400 300 200 100 0

100 90 80 70 60 50 40 30 20 10 0

2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Measles cases Routine coverage MCV-1 Routine coverage MCV-2 SIA coverage

Measles-rubella-SIA 9 months to 14 years (96%)

Measles-rubella-SIA 9 months to <5 years (99.5%) 900

800 700 600 500 400 300 200 100 0

100 90 80 70 60 50 40 30 20 10 0

2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Rubella cases Routine coverage RCV-1 Routine coverage RCV-2 SIA coverage

96 99

78

4 1

9

Risk status Number of districts Popula on propor on

1. Very high risk 0 0

2. High risk 1 (Ainaro) 5%

3. Medium risk 2 (Dili & Viqueque) 30%

4. Low risk 10 65%

High Risk Medium Risk Low Risk Unknown

Dili Lautem

Baucau Viqueque Manufahi

Covalima Oecusse

Ainar

o

Manatuto

Ermer a Bobonaro

Liquisa

Aileu

317

Health posts at the village level

MCV: Measles-containing vaccine SIA: Supplementary immunizati on acti vity

MR: Measles–rubella

CRS: Congenital rubella syndrome

(3)

Timor-Leste has met the criteria for measles elimination and control of rubella and congenital rubella syndrome. To sustain these achievements,

it is important to implement the post-elimination sustainability plan, including the outbreak preparedness and response plan; enhance capacity to strengthen outbreak investigation and response; further strengthen routine immunization for MCV1 and MCV2; enhance local

capacity to strengthen VPD surveillance with focus on measles and rubella; strengthen cross-border initiatives; strengthen and ensure

functioning of surveillance and laboratory system.

What made Timor-Leste successful in eliminating measles and controlling rubella?

 Strong politi cal commitment

 Functi oning health system

 Strengthened routi ne immunizati on coverage

 Enhanced surveillance

 Regular review of programme implementati on at nati onal and subnati onal levels

 Intersectoral collaborati on

 Moti vated workforce

 Community parti cipati on

 Strengthened laboratory networks

 Strong technical assistance

 Coordinated partner support

Measles

and Rubella at a Glance

Timor-Leste, 2018

Flow chart of immunization service delivery system

Mother and Child Health Department

Community Health Service

Health Posts Private Clinic

Na onal Director for Public Health Director General for Service Delivery

Partners HMIS

Partners District Health Service Hospital

Laboratory

Community Outreach

Services

Na onal EPI Program

Immunization coverage at subnational level, 2017

Aileu Ainaro Bobonaro Baucau

Dili Covalima

Ermera Lautem Liquisa Manatuto Manufahi Oecusse Viqueque

0 30 60 90 120 150

Coverage of 1st dose (%) Coverage of 2nd dose (%)

Servisu Integrado Saude Communitario (Integrated Community Health Services)

Programa Nasional Saudena Familia (The Na onal Program of Health in the

Family – Domiciliary Visits)

All images © Shobhan Singh - Communica on O cer/WHO Country O ce for Timor-Leste

Références

Documents relatifs

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 and communication with the country Incidence calculated per 1 million population. ND = Data not

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 Incidence calculated per 1 million population. ND = Data not available; NA=

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 ND = Data not available; NA= Not applicable. A proficient laboratory is WHO accredited and/or has

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 Incidence calculated per 1 million population. ND = Data not available; NA=

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 and communication with the country Incidence calculated per 1 million population. ND = Data not

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 Incidence calculated per 1 million population. ND = Data not available; NA=

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 ND = Data not available; NA= Not applicable. A proficient laboratory is WHO accredited and/or has

Source: Measles and rubella elimination Annual Status Update report, 2014-2018 Incidence calculated per 1 million population. ND = Data not available; NA=